Loading
Loading…
Loading…
Tender Value
Refer Docs
Closing Date
30 Jun 2026, 3:00 pm
Similar tender results from the same govt authority in the past 3 years.
Trastuzumab Deruxtecan concentrate solution for infusion 100 mg/vial [Product should be available in the Manufacturing firm's approved product list of Railway Board
22265414A
22265414A
Limited - Indigenous
Unknown (Unspecified Location)
₹0
Exempted
17 Jun 2026
17 Jun 2026
Description :Trastuzumab Deruxtecan concentrate solution for infusion 100 mg/vial [Product should b e available in the Manufacturing firm's approved product list of Railway Board] [ Rate of supply 1 units per Month , Commencement Time Allowed -1 Day ] MD/BRSH/SEALDAH As per tender 12.00 Numbers Consignee Conditions The purchaser may at its discretion modify the minimum rate of supply.
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
Instructions_to_tenderes_for_manual_and_Etenders_22_11_25_1.pdf _manual_and_ E
ATTACHMENT
EASTERNRAILWAY_TenderCondition_Revision_27062025_8_1.pdf
ATTACHMENT
Instructions_to_tenderes_for_manual_and_Etenders_30.01.2026.pdf _manual_and_ E
ATTACHMENT
EASTERNRAILWAY_TenderCondition_Revision_111224_4.pdf
ATTACHMENT
EASTERNRAILWAY_TenderCondition_Revision_060524.pdf
ATTACHMENT
Instructions_to_tenderes_for_manual_and_Etenders_22_11_25_1.pdf
ATTACHMENT
Instructions_to_tenderes_for_manual_and_Etenders_30.01.2026.pdf
ATTACHMENT
Download all tender documents and submit your bid